HemoSonics LLC has been honored with the prestigious 2025 Supplier Horizon Award from Premier, Inc., a leading healthcare improvement company, recognizing the company's exceptional contributions to acute bleeding management and its support of Premier member hospitals. The award celebrates HemoSonics’ Quantra® Hemostasis System—a revolutionary point-of-care solution that enables rapid, comprehensive coagulation assessment in under 15 minutes. Selected as one of just 13 suppliers for this distinction, HemoSonics was acknowledged for its clinical excellence, strong customer engagement, and commitment to improving care delivery through innovation and value.

The Quantra System, built around HemoSonics’ proprietary SEER Sonorheometry® technology, offers real-time, lab-quality results that empower clinicians to make informed decisions during complex surgeries such as cardiovascular, orthopedic, and trauma procedures. By streamlining coagulation testing at the bedside and reducing reliance on traditional lab workflows, Quantra supports the timely administration of blood products, helping to avoid unnecessary transfusions and improve surgical outcomes. Its ease of use, minimal training requirements, and operational efficiency have made it a valuable asset to hospitals looking to standardize and enhance their viscoelastic testing programs.

Looking ahead, HemoSonics is well-positioned for continued growth and impact in the global acute care diagnostics landscape. As hospitals and surgical centers seek faster, more precise tools for managing intraoperative bleeding and resource allocation, solutions like Quantra will play a central role in transforming care pathways. The 2025 Supplier Horizon Award underscores HemoSonics’ leadership in this critical area, reinforcing the company’s mission to deliver actionable diagnostic insights that improve outcomes, reduce costs, and enable patient-centered care when it matters most.